{"gene":"BACE1","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2006,"finding":"BACE1 cleaves neuregulin-1 (NRG1) in the CNS and PNS; genetic deletion of Bace1 in mice causes hypomyelination, delays myelination, reduces myelin sheath thickness, and decreases phosphorylated Akt in myelin-forming cells, with full-length NRG1 accumulating and its cleavage product reduced in null mice, establishing BACE1-mediated NRG1 processing as a regulator of myelination via the neuregulin-Akt signaling pathway.","method":"Bace1 knockout mice, western blotting, neurological behavioral assays, immunohistochemistry","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular phenotype, biochemical readout of substrate accumulation and downstream signaling, independently replicated in subsequent studies","pmids":["17099708"],"is_preprint":false},{"year":2007,"finding":"GGA3 (an adaptor protein involved in BACE1 trafficking) controls BACE1 protein stability post-translationally; RNAi depletion of GGA3 elevates BACE1 levels and beta-secretase activity via caspase-activated posttranslational stabilization of BACE1, and GGA3 levels are inversely correlated with BACE1 levels in AD brain and following cerebral ischemia.","method":"RNAi knockdown, western blotting, caspase inhibition, AD brain samples, cerebral ischemia model","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — RNAi with defined biochemical phenotype, multiple orthogonal methods (cell lines, ischemia model, human brain), mechanistic follow-up with caspase activation","pmids":["17553422"],"is_preprint":false},{"year":2007,"finding":"BACE1 cleaves the voltage-gated sodium channel beta2-subunit (Nav1 β2); BACE1-gamma-secretase sequential cleavage releases the β2 intracellular domain, which increases Nav1.1 alpha-subunit mRNA and protein, but Nav1.1 is retained intracellularly, reducing cell-surface sodium current densities in neuroblastoma cells and hippocampal neurons from BACE1-transgenic mice.","method":"BACE1-transgenic mice, neuroblastoma cell overexpression, electrophysiology (sodium current recordings), western blotting, mRNA quantification","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (overexpression, transgenic mice, electrophysiology, biochemical assays) in one study","pmids":["17576410"],"is_preprint":false},{"year":2001,"finding":"BACE1 (Asp2) is compartmentalized into low-buoyant density, non-caveolar lipid rafts; both BACE1 protein and activity co-fractionate with raft markers in three distinct cell lines by detergent and non-detergent methods, and cholesterol depletion abolishes this raft association.","method":"Density gradient fractionation (detergent and non-detergent), immunoisolation of caveolin-containing vesicles, cholesterol depletion, enzyme activity assays","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple cell lines, orthogonal fractionation methods, cholesterol depletion functional validation","pmids":["11525745"],"is_preprint":false},{"year":2005,"finding":"BACE1 is degraded via the lysosomal pathway; lysosomal inhibitors (chloroquine, NH4Cl) cause accumulation of BACE1 in LAMP2-positive late endosomal/lysosomal compartments, and the di-leucine motif (LL499/500) in the BACE1 C-terminus is required for efficient lysosomal sorting, as the LL/AA mutant shows impaired co-localization with LAMP2-positive compartments.","method":"Lysosomal inhibitor treatment, site-directed mutagenesis (LL/AA), immunofluorescence co-localization, western blotting in multiple cell types including primary neurons","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — mutagenesis of sorting motif, multiple cell types including neurons, orthogonal localization and biochemical methods","pmids":["16033761"],"is_preprint":false},{"year":2004,"finding":"BACE1 protein is ubiquitinated and degraded via the ubiquitin-proteasome pathway; proteasome inhibition (lactacystin) increases BACE1 protein levels in a time- and dose-dependent manner and elevates APP C99 production and Aβ generation.","method":"Proteasome inhibitor treatment (lactacystin), ubiquitination immunoprecipitation, western blotting, Aβ/C99 measurement","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, pharmacological inhibition plus ubiquitination IP, single method for ubiquitination","pmids":["15289451"],"is_preprint":false},{"year":2008,"finding":"BACE1-dependent NRG1 processing regulates ErbB4 signaling; BACE1-null mice show reduced ErbB4-PSD95 interaction, decreased hippocampal dendritic spine density, and schizophrenia-like behaviors (impaired prepulse inhibition, hyperactivity, cognitive deficits), which are partially rescued by the antipsychotic clozapine, linking BACE1-NRG1/ErbB4 signaling to synaptic function and psychiatric phenotypes.","method":"BACE1 knockout mice, behavioral assays, co-immunoprecipitation (ErbB4-PSD95), dendritic spine quantification, pharmacological rescue with clozapine","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO with multiple orthogonal readouts (behavioral, biochemical, morphological, pharmacological rescue), single lab","pmids":["18385378"],"is_preprint":false},{"year":2012,"finding":"GSK3β specifically (not GSK3α) regulates BACE1 gene transcription and expression via NF-κB signaling; specific inhibition of GSK3β reduces BACE1-mediated APP cleavage and Aβ production, decreases amyloid deposition, and rescues memory deficits in double-transgenic AD mice.","method":"Isoform-specific inhibition, NF-κB reporter assays, BACE1 transcription assays, transgenic AD mouse model, behavioral testing","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (transcription, cell-based, in vivo), single lab","pmids":["23202730"],"is_preprint":false},{"year":2012,"finding":"BACE1 is a major neuronal sheddase; proteome-wide SPECS method identified 34 novel BACE1 substrates in primary neurons including seizure-protein 6, L1, CHL1, and contactin-2, validated in BACE1 inhibitor-treated and BACE1 knockout mouse brains, pointing to roles in neurite outgrowth and synapse formation.","method":"Metabolic glycan labeling, click chemistry-mediated biotinylation (SPECS), mass spectrometry, validation in BACE1 KO and inhibitor-treated mouse brains","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — novel proteomics method with in vivo genetic validation in KO mice and pharmacological inhibition, multiple substrates validated","pmids":["22728825"],"is_preprint":false},{"year":2011,"finding":"Sphingosine-1-phosphate (S1P) directly binds full-length BACE1 and increases its proteolytic activity; inhibition of sphingosine kinase (SphK) or knockdown of SphK or overexpression of S1P-degrading enzymes decreases BACE1 activity and Aβ production in mouse neurons.","method":"Direct binding assay (S1P to BACE1), SphK inhibitor treatment, RNAi knockdown, overexpression of S1P-degrading enzymes, BACE1 activity assays","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding plus functional RNAi and pharmacological approaches, single lab","pmids":["21543615"],"is_preprint":false},{"year":2011,"finding":"BACE1 and ADAM10 cleave type I and III neuregulin-1 (Nrg1) at two adjacent sites (BACE1 site 8 amino acids downstream of ADAM10 site); both generate signaling-capable N-terminal fragments activating ErbB receptors (phosphorylated Akt and ERK), but specific inhibition of BACE1 (not ADAM10) impairs myelination in co-culture, indicating BACE1 cleavage of Nrg1 is specifically required for myelination.","method":"Cleavage site mapping, optimized electrophoresis, ErbB receptor phosphorylation assays, BACE1/ADAM10 inhibitor treatment, co-culture myelination assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — biochemical cleavage site mapping plus functional myelination assay with specific inhibitors, multiple orthogonal methods","pmids":["21576249"],"is_preprint":false},{"year":2013,"finding":"BACE1 directly cleaves membrane-anchored Jagged1 (Jag1), reducing Jag1 shedding; in BACE1-null mice, reduced Jag1 shedding enhances Notch signaling via cell-cell juxtacrine interactions, leading to increased astrogenesis and decreased neurogenesis in the hippocampus during early development.","method":"BACE1 knockout mice, overexpression of BACE1, biochemical cleavage assays, cell counting (neurogenesis/astrogenesis), Notch signaling assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — KO plus overexpression with biochemical and cellular readouts, multiple orthogonal methods in single lab","pmids":["23831026"],"is_preprint":false},{"year":2013,"finding":"APP and BACE-1 are largely segregated in distinct vesicles under physiological conditions in neurons (BACE-1 in acidic recycling endosomes; APP in Golgi-derived vesicles); neuronal activity triggers APP routing into BACE-1-positive recycling endosomes via a clathrin-dependent endocytic mechanism, enabling their convergence and amyloidogenic processing.","method":"Live imaging of dendritic APP/BACE-1-containing vesicles in hippocampal neurons, clathrin inhibition, subcellular fractionation, activity induction paradigms","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Moderate — live-cell imaging with mechanistic perturbation (clathrin inhibition), multiple orthogonal approaches in single lab","pmids":["23931995"],"is_preprint":false},{"year":2015,"finding":"APP and BACE-1 interact in both biosynthetic and endocytic compartments, particularly at recycling microdomains such as dendritic spines and presynaptic boutons; in axons, APP and BACE-1 are co-transported and interact during transit; the Alzheimer's disease-protective Icelandic mutation greatly attenuates APP-BACE-1 interaction.","method":"Fluorescence complementation optical assay for APP-BACE-1 interaction, endosomal fate-tracking assays in hippocampal neurons, Icelandic mutant APP analysis","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — novel in cellulo interaction assay with multiple complementary live-imaging approaches, genetic variant validation","pmids":["26642089"],"is_preprint":false},{"year":2016,"finding":"USP8, an endosome-associated deubiquitinating enzyme, deubiquitinates BACE1 at lysine 501, maintaining BACE1 in recycling endosomes; RNAi depletion of USP8 increases BACE1 ubiquitination, promotes BACE1 accumulation in early and late endosomes/lysosomes, reduces BACE1 levels, and decreases BACE1-mediated APP cleavage and Aβ generation.","method":"RNAi knockdown of USP8, ubiquitination assays, endosomal co-localization, western blotting, Aβ/sAPPβ measurement in H4 neuroglioma cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi with multiple orthogonal readouts (ubiquitination, localization, substrate processing), single lab","pmids":["27302062"],"is_preprint":false},{"year":2012,"finding":"SUMO1 interacts with the dileucine motif of BACE1 and regulates BACE1 protein levels; altering SUMO1 (but not SUMO2 or SUMO3 alone) modulates BACE1 protein levels and consequently APP processing and Aβ generation; BACE1 levels increase in response to Aβ or apoptosis in a SUMO1-dependent manner.","method":"Co-immunoprecipitation, gain/loss of function experiments, western blotting, Aβ measurement, APP transgenic mice","journal":"Neurobiology of aging","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP plus functional gain/loss experiments, single lab, multiple orthogonal approaches","pmids":["22975420"],"is_preprint":false},{"year":2016,"finding":"Autophagy-lysosomal pathway regulates BACE1 trafficking and degradation; induction of neuronal autophagy enhances BACE1 turnover suppressible by lysosomal inhibition; BACE1 co-migrates with autophagic vacuoles along axons in a retrograde manner; in mutant APP transgenic neurons, autophagic vacuole-associated BACE1 accumulates in distal axons enhancing β-cleavage, and Snapin-enhanced retrograde transport restores BACE1 delivery to lysosomes.","method":"Live imaging of axonal transport, autophagy induction/inhibition, lysosomal inhibition, Snapin overexpression, mutant APP transgenic neurons and mice","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — live imaging plus genetic and pharmacological perturbations, single lab","pmids":["28028177"],"is_preprint":false},{"year":2015,"finding":"BACE1 is highly enriched in synaptic vesicles isolated from rat brain; BACE1 localizes in close proximity to synaptic vesicle marker synaptophysin in intact hippocampal neurons as shown by proximity ligation assay, supporting BACE1-mediated APP processing at the synapse.","method":"Controlled-pore glass chromatography synaptic vesicle isolation, western blotting, proximity ligation assay in primary hippocampal neurons","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — subcellular fractionation plus in situ proximity assay, multiple orthogonal localization methods, single lab","pmids":["26296617"],"is_preprint":false},{"year":2014,"finding":"Reticulon 3 (RTN3) interacts with BACE1 and negatively regulates its activity; RTN3-null mice show increased BACE1 protein levels, enhanced APP processing at the β-secretase site, and accelerated amyloid deposition in Alzheimer's mouse models.","method":"RTN3 knockout mice, western blotting, APP processing biochemical assays, amyloid plaque quantification in AD mouse models","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with biochemical and in vivo amyloid readouts, single lab","pmids":["25319692"],"is_preprint":false},{"year":2014,"finding":"BACE1 cleaves human contactin-2 at a site near its GPI membrane linker domain; BACE1 overexpression increases soluble contactin-2 in conditioned media, pharmacological BACE1 inhibition decreases it, and mutation of the BACE1 cleavage site (1008MM/AA) dramatically impairs contactin-2 shedding; BACE1 activity tightly regulates contactin-2 cell surface levels in CHO cells and primary neurons.","method":"BACE1 overexpression, pharmacological inhibition, cleavage site mutagenesis, immunofluorescence, surface biotinylation assays, conditioned media ELISA","journal":"Molecular neurodegeneration","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — mutagenesis of cleavage site plus multiple functional readouts (overexpression, inhibition, surface biotinylation), single lab","pmids":["24405708"],"is_preprint":false},{"year":2012,"finding":"Oxidative stress increases BACE1 protein levels via the PKR-eIF2α pathway; specific inhibition of PKR-eIF2α signaling attenuates BACE1 protein levels under H2O2-induced oxidative stress in human neuroblastoma cells, and activated PKR, phospho-eIF2α, and BACE1 are co-elevated in AD cortices and APP/PS1 mice.","method":"Western blotting, PKR/eIF2α inhibitors, H2O2 treatment, human AD brain samples, APP/PS1 knock-in mice","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological pathway inhibition plus human tissue correlation, multiple model systems, single lab","pmids":["22306812"],"is_preprint":false},{"year":2011,"finding":"NO differentially modulates BACE1: low concentrations (<100 nM NO) suppress BACE1 transcription via NO/cGMP-PKG signaling (likely through PGC-1α activation), while higher NO levels (0.1-100 μM) induce S-nitrosylation of BACE1 at cysteine residues, inactivating the enzyme without altering expression; H2O2 upregulates BACE1 expression via transcriptional activation.","method":"BACE1 activity assays, transcription assays, S-nitrosylation biochemistry, signaling pathway inhibitors (PKG inhibitor), cultured neurons","journal":"Molecular neurodegeneration","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple mechanistic experiments (transcription, post-translational modification, pathway inhibition), single lab","pmids":["21371311"],"is_preprint":false},{"year":2017,"finding":"BACE1 regulates retrograde trafficking from endosomes to the TGN via Par3/aPKC-mediated phosphorylation of BACE1 at Ser498, which promotes BACE1-PACS1 interaction; in human AD brains, Ser498 phosphorylation of BACE1 is significantly decreased, suggesting defective retrograde transport contributes to BACE1 endosomal accumulation.","method":"Par3/aPKC overexpression and knockdown, BACE1 Ser498 phospho-specific analysis, co-immunoprecipitation (BACE1-PACS1), endosomal trafficking assays, human AD brain western blotting","journal":"Neurobiology of aging","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple molecular approaches (Co-IP, phospho-assays, trafficking assays, human tissue), single lab","pmids":["28946017"],"is_preprint":false},{"year":2012,"finding":"Sorting nexin 12 (SNX12) interacts with BACE1 in early endosomes and regulates BACE1 endocytosis; SNX12 overexpression reduces Aβ, sAPPβ, and APP β-CTF without altering γ-secretase activity or in vitro BACE1 activity, while SNX12 downregulation increases BACE1 endocytosis and reduces cell surface BACE1.","method":"Co-immunoprecipitation (SNX12-BACE1), overexpression/knockdown, APP processing biochemical assays, endocytosis assays, human AD brain western blotting","journal":"Molecular neurodegeneration","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP plus functional gain/loss experiments, multiple readouts, single lab","pmids":["22709416"],"is_preprint":false},{"year":2006,"finding":"BACE1 in human brain tissue occurs as a dimer, whereas the soluble ectodomain of truncated BACE1 occurs exclusively in monomeric form; mutational analysis of active sites suggests BACE1 may acquire specific catalytic activity upon oligomerization stabilized by transmembrane and cytoplasmic domains.","method":"Analysis of BACE1 in human brain tissue, truncation and active-site mutagenesis, biochemical dimerization analysis","journal":"Neuro-degenerative diseases","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single study, limited mechanistic detail in abstract, mutational analysis not fully described","pmids":["17047367"],"is_preprint":false},{"year":2015,"finding":"BACE1 in axons and Schwann cells is equally required for optimal remyelination of injured sciatic nerves; nerve injury induces BACE1 transcription and elevated BACE1 protein in Schwann cells, where type I (not type III) Nrg1 is induced, and abolished Nrg1 cleavage in BACE1-null Schwann cells contributes to impaired remyelination.","method":"Sciatic nerve segment transplantation (swapping between BACE1-null and wild-type), nerve injury models, western blotting, immunohistochemistry, BACE1 transcript quantification","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — elegant cell-type-specific transplantation experiment with defined substrate and cellular readouts, single lab","pmids":["25740511"],"is_preprint":false},{"year":2020,"finding":"AP-2 (protein complex-2 endocytic adaptor) prevents amyloidogenesis by regulating BACE1 endosomal trafficking and delivery to lysosomes downstream of BACE1 endocytosis; conditional AP-2 knockout mice show increased Aβ production due to BACE1 accumulation in late endosomes/autophagosomes, and deletion of BACE1 in AP-2 KO neurons decreases amyloidogenesis and mitigates synapse loss.","method":"Conditional AP-2 KO mice, iPSC-derived AD patient neurons, western blotting, endosomal localization, Aβ measurement, genetic rescue (BACE1 deletion in AP-2 KO neurons)","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO plus genetic rescue, iPSC human neurons, multiple orthogonal readouts","pmids":["32323475"],"is_preprint":false},{"year":2021,"finding":"BACE1 is required for optimal synaptic vesicle release; BACE1 deficiency or inhibition decreases synaptic vesicle docking in active zones, reduces hippocampal LTP, and impairs learning; levels of mGluR1 are reduced in BACE1-null mice, and mGluR1 positive allosteric modulators rescue LTP and cognitive deficits caused by BACE1 deficiency or inhibition.","method":"BACE1 knockout mice, BACE1 inhibitors (Verubecestat, Lanabecestat), electrophysiology (LTP), electron microscopy (vesicle docking), behavioral testing, mGluR1 PAM pharmacological rescue","journal":"Molecular psychiatry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO plus pharmacological inhibition, EM for vesicle docking, electrophysiology, behavioral rescue experiments","pmids":["34158621"],"is_preprint":false},{"year":2022,"finding":"Microglial BACE1 deficiency enhances Aβ clearance (not by reducing APP processing) by increasing a phagocytic microglial gene signature and enhancing autophagolysosome function; BACE1 deletion in microglia activates PI3K-mTOR-HIF-1α signaling (mTOR phosphorylated at Ser2448) and abolishes cleavage of IL-1R2 and Toll-like receptors, contributing to enhanced phagocytic signaling via PI3K and p38 MAPK.","method":"Microglial-specific Bace1 deletion in 5xFAD mice, scRNA-seq, amyloid plaque quantification, LTP measurement, in vitro BACE1 silencing/inhibition in microglia-derived cells, phagocytosis assays","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific KO, scRNA-seq, multiple functional assays (phagocytosis, LTP, signaling pathway), single lab with multiple orthogonal methods","pmids":["35857844"],"is_preprint":false},{"year":2022,"finding":"BACE1 deficiency in microglia facilitates their transition from homeostatic to stage 1 disease-associated microglia (DAM-1) by elevating transcription factors (Jun, Jund, Btg2, Erg1, Junb, Fos, Fosb); abolished cleavage of IL-1R2 and Toll-like receptors by BACE1 inhibition contributes to enhanced PI3K and p38 MAPK signaling.","method":"Targeted Bace1 deletion in adult 5xFAD microglia, scRNA-seq of purified microglia, BACE1 pharmacological inhibition in microglia-derived cells, amyloid plaque quantification","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO, scRNA-seq, pharmacological validation, multiple signaling pathway readouts","pmids":["35714196"],"is_preprint":false},{"year":2023,"finding":"BACE1 in astrocytes cleaves insulin receptors (IR) on the astrocyte surface; BACE1 deficiency abolishes IR cleavage, enhancing insulin receptor pathway signaling and upregulating Clusterin (CLU) and Cxcl14 expression; elevated astrocytic CLU enhances Aβ uptake and degradation, and astrocyte-specific BACE1 knockout in 5xFAD mice significantly reduces cortical amyloid plaque load.","method":"Astrocyte-specific Bace1 KO (Bace1fl/fl;Gfap-cre), scRNA-seq of purified astrocytes, siRNA knockdown, western blotting, Aβ uptake/degradation assays, amyloid plaque quantification","journal":"Molecular neurodegeneration","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific KO, scRNA-seq, mechanistic substrate identification (IR), siRNA rescue, in vivo plaque quantification","pmids":["37143090"],"is_preprint":false},{"year":2015,"finding":"sAPPα (the product of α-secretase cleavage of AβPP) is a potent endogenous direct inhibitor of BACE1, likely by an allosteric mechanism; sAPPβ (differing only by a 16-amino acid C-terminal truncation) adopts a structurally distinct conformation by small-angle X-ray scattering and does not inhibit BACE1.","method":"In vitro BACE1 inhibition assay with recombinant sAPPα, small-angle X-ray scattering (structural comparison of sAPPα vs sAPPβ)","journal":"Journal of Alzheimer's disease","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro enzyme assay with structural validation, single lab, no mutagenesis to confirm allosteric site","pmids":["26401691"],"is_preprint":false},{"year":2009,"finding":"Mutant presenilin 1 (PS1) increases BACE1 expression and activity; this upregulation requires gamma-secretase cleavage of APP and is proportional to secreted Aβ42 (not AICD), identifying Aβ42 as the APP derivative that mediates PS1 mutation-induced BACE1 overexpression.","method":"Transient and stable transfection with PS1 mutants, gamma-secretase inhibition, western blotting, BACE1 activity assays, PS1 mutant knock-in mice, human FAD brain tissue","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple cell systems plus knock-in mice plus human tissue, gamma-secretase inhibition to parse mechanism, single lab","pmids":["19196715"],"is_preprint":false},{"year":2017,"finding":"p75 neurotrophin receptor interacts with BACE1, and this interaction is enhanced by Aβ; p75 promotes BACE1 and APP co-localization in early endosomes via JNK-mediated phosphorylation of APP-Thr668 and BACE1-Ser498, enhancing amyloidogenesis in cortical neurons.","method":"Co-immunoprecipitation (p75-BACE1), immunofluorescence co-localization, early endosome fractionation, JNK inhibition, cortical neuron cultures","journal":"Journal of neurochemistry","confidence":"Low","confidence_rationale":"Tier 3 / Weak — Co-IP plus co-localization, single lab, limited mechanistic depth in abstract","pmids":["28869759"],"is_preprint":false},{"year":2007,"finding":"Receptor tyrosine kinase (RTK) stimulation (EGF, NGF receptors) enhances BACE activity and Aβ production by promoting BACE1 internalization into endosomes and Golgi; this enhancement requires Src family kinase activity and endosomal internalization (Rab5-dependent), and is abolished by dominant-negative Rab5 or Src inhibitors.","method":"RTK stimulation (EGF, NGF), Src inhibitors, Src RNAi, dominant-negative Rab5, BACE1 activity assays, Aβ measurement, mouse hippocampus experiments","journal":"Cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple perturbations (pharmacological, genetic, dominant-negative) with in vitro and in vivo readouts, single lab","pmids":["17325690"],"is_preprint":false},{"year":2021,"finding":"Rab35 negatively regulates Aβ production by sorting APP and BACE1 out of the endosomal network via distinct effectors: OCRL mediates BACE1 trafficking and ACAP2 mediates APP trafficking; Rab35 overexpression prevents amyloidogenic trafficking of APP and BACE1 induced by high glucocorticoid levels.","method":"Rab35 overexpression/knockdown, effector (OCRL, ACAP2) studies, APP/BACE1 endosomal trafficking assays, Aβ measurement, glucocorticoid treatment","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — overexpression/knockdown with defined effectors, multiple trafficking readouts, single lab","pmids":["34876559"],"is_preprint":false},{"year":2011,"finding":"Aβ42 activates BACE1 gene transcription through the JNK/c-jun signaling pathway, creating a positive feedback loop; Aβ40 has much less effect on BACE1 expression.","method":"Aβ42/Aβ40 treatment of neuronal cells, BACE1 transcription assays, JNK pathway inhibition","journal":"Journal of Alzheimer's disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological pathway inhibition with transcription readout, specificity shown by Aβ40 vs Aβ42 comparison, single lab","pmids":["21897006"],"is_preprint":false},{"year":2019,"finding":"MMP13 regulates BACE1 protein levels post-transcriptionally through PI3K signaling and eIF4B-mediated translational control; eIF4B phosphorylation at Ser422 mediates MMP13's effect on BACE1, and deletion of the BACE1 5'UTR abolishes MMP13-mediated regulation; MMP13 inhibition reduces BACE1 levels and Aβ deposition in APP/PS1 AD mice.","method":"High-throughput BACE1 promoter/5'UTR luciferase screen, eIF4B mutagenesis (S422R), 5'UTR deletion, PI3K inhibition, APP/PS1 mouse hippocampal Mmp13 knockdown, Aβ quantification","journal":"Brain","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal approaches (mutagenesis, deletion, pharmacological, in vivo KD), single lab","pmids":["30596903"],"is_preprint":false}],"current_model":"BACE1 is a transmembrane aspartyl protease that functions as the rate-limiting β-secretase for APP cleavage and Aβ generation, and as a broad neuronal sheddase processing multiple substrates including neuregulin-1 (regulating myelination and ErbB/Akt signaling), Nav1 β2-subunit (controlling sodium channel surface expression), Jagged1 (regulating Notch-dependent neurogenesis/astrogenesis), contactin-2, and astrocytic insulin receptors; its activity is spatially regulated by endosomal trafficking controlled by GGA3, USP8, AP-2, SNX12, Par3/aPKC-mediated Ser498 phosphorylation, and Rab35, with lipid raft compartmentalization and lysosomal degradation via a di-leucine sorting motif, while its levels are regulated transcriptionally (via NF-κB/GSK3β, JNK/c-jun, NO/cGMP-PKG) and post-translationally (ubiquitination, SUMO1, S-nitrosylation, and autophagy-mediated turnover), and it is additionally required for synaptic vesicle docking and microglial DAM transition."},"narrative":{"mechanistic_narrative":"BACE1 is a membrane-anchored aspartyl protease that functions as the principal neuronal β-secretase and a broad sheddase, governing both amyloidogenic APP processing and the proteolytic regulation of diverse cell-surface and signaling proteins in the nervous system [PMID:22728825, PMID:23931995]. Beyond APP, BACE1 cleaves neuregulin-1 to drive ErbB/Akt signaling required for CNS and PNS myelination and remyelination after nerve injury [PMID:17099708, PMID:21576249, PMID:25740511], processes the voltage-gated sodium channel β2-subunit to control Nav1.1 surface expression and sodium current [PMID:17576410], sheds Jagged1 to restrain Notch-dependent astrogenesis and promote neurogenesis [PMID:23831026], and cleaves contactin-2 and a wider set of neuronal substrates implicated in neurite outgrowth and synapse formation [PMID:22728825, PMID:24405708]; in non-neuronal cells it cleaves astrocytic insulin receptors to suppress Clusterin-mediated Aβ clearance [PMID:37143090] and processes IL-1R2 and Toll-like receptors in microglia to restrain phagocytic disease-associated microglial signaling [PMID:35857844, PMID:35714196]. The enzyme's activity is set by its subcellular itinerary: BACE1 partitions into cholesterol-dependent lipid rafts [PMID:11525745], converges with APP in acidic recycling endosomes upon neuronal activity for amyloidogenic cleavage [PMID:23931995, PMID:26642089], and is sorted for degradation through a C-terminal di-leucine motif to lysosomes and via autophagy [PMID:16033761, PMID:28028177]. This trafficking is controlled by an array of factors including the deubiquitinase USP8 (which stabilizes endosomal BACE1 via Lys501) [PMID:27302062], the adaptors GGA3 and AP-2 [PMID:17553422, PMID:32323475], SNX12, Rab35, and Par3/aPKC-mediated Ser498 phosphorylation that promotes PACS1-dependent retrograde transport [PMID:28946017, PMID:22709416, PMID:34876559]. BACE1 levels are further tuned transcriptionally through GSK3β/NF-κB and Aβ42-driven JNK/c-jun feedback, and post-translationally by ubiquitination, SUMO1, and S-nitrosylation [PMID:15289451, PMID:23202730, PMID:21371311, PMID:21897006]. Functionally, BACE1 is required for synaptic vesicle docking, hippocampal LTP, and learning, acting in part through mGluR1 [PMID:34158621].","teleology":[{"year":2001,"claim":"Establishing where BACE1 acts within the membrane explained how its activity could be spatially compartmentalized rather than uniformly distributed.","evidence":"Density gradient fractionation and cholesterol depletion across three cell lines","pmids":["11525745"],"confidence":"High","gaps":["Did not connect raft localization to a specific substrate cleavage event","Mechanism of raft targeting not defined"]},{"year":2005,"claim":"Identifying a di-leucine sorting motif and lysosomal degradation route defined how cells set steady-state BACE1 levels post-translationally.","evidence":"Lysosomal inhibitors plus LL/AA mutagenesis and LAMP2 co-localization in multiple cell types including neurons","pmids":["16033761"],"confidence":"High","gaps":["Did not identify the adaptors recognizing the motif","Link to amyloid output not addressed"]},{"year":2006,"claim":"Demonstrating BACE1-dependent neuregulin-1 cleavage uncovered a physiological role beyond amyloid, linking the protease to myelination through neuregulin-Akt signaling.","evidence":"Bace1 knockout mice with NRG1 fragment quantification, myelin morphology, and phospho-Akt readouts","pmids":["17099708"],"confidence":"High","gaps":["Cleavage site not mapped in this study","Did not distinguish neuronal vs glial source of cleavage"]},{"year":2007,"claim":"Showing GGA3 controls BACE1 stability and that BACE1 cleaves the Nav1 β2-subunit extended the enzyme's regulation and substrate repertoire into channel surface control and ischemic stress.","evidence":"GGA3 RNAi with caspase inhibition and AD/ischemia tissue; β2 cleavage with electrophysiology in transgenic mice","pmids":["17553422","17576410"],"confidence":"High","gaps":["Caspase-cleaved GGA3 species not fully resolved","Functional consequence of β2 cleavage in vivo for excitability untested"]},{"year":2007,"claim":"RTK signaling was shown to acutely enhance BACE1 activity by driving its Rab5/Src-dependent endosomal internalization, tying receptor signaling to amyloidogenesis.","evidence":"EGF/NGF stimulation with Src inhibitors, Src RNAi, and dominant-negative Rab5","pmids":["17325690"],"confidence":"Medium","gaps":["Direct phosphorylation target linking RTK to BACE1 trafficking not defined","Single lab"]},{"year":2008,"claim":"Linking BACE1-NRG1 processing to ErbB4-PSD95 signaling connected the protease to synaptic structure and psychiatric-relevant behavior.","evidence":"BACE1 KO mice with behavioral assays, ErbB4-PSD95 Co-IP, spine quantification, and clozapine rescue","pmids":["18385378"],"confidence":"High","gaps":["Only partial pharmacological rescue","Causal chain from NRG1 fragment to spine loss not fully isolated"]},{"year":2009,"claim":"Identifying Aβ42 as the APP derivative driving PS1-mutation-induced BACE1 upregulation revealed a feed-forward link between γ-secretase products and β-secretase levels.","evidence":"PS1 mutant transfection and knock-in mice with γ-secretase inhibition and human FAD tissue","pmids":["19196715"],"confidence":"Medium","gaps":["Transcriptional vs post-translational basis not separated here","Single lab"]},{"year":2011,"claim":"Multiple regulatory inputs (S1P binding, NO/cGMP and S-nitrosylation, Aβ42/JNK feedback) were resolved, showing BACE1 activity and expression are tuned by lipids, redox state, and product feedback.","evidence":"Direct S1P binding and SphK perturbation; S-nitrosylation biochemistry with PKG inhibition; Aβ42 vs Aβ40 with JNK inhibition; NRG1 cleavage site mapping with myelination co-culture","pmids":["21543615","21371311","21897006","21576249"],"confidence":"Medium","gaps":["S1P binding site on BACE1 not mapped","Concentration thresholds for NO effects from cell culture","Each mechanism from a single lab"]},{"year":2012,"claim":"Proteome-wide substrate discovery established BACE1 as a major neuronal sheddase with dozens of substrates, while SUMO1, GSK3β/NF-κB, and PKR-eIF2α regulation defined the modification and transcriptional control layers.","evidence":"SPECS proteomics with KO/inhibitor validation; SUMO1 Co-IP and gain/loss; GSK3β isoform-specific inhibition with AD mice; PKR-eIF2α inhibition under oxidative stress; SNX12 Co-IP and trafficking","pmids":["22728825","22975420","23202730","22306812","22709416"],"confidence":"High","gaps":["Physiological function of most novel substrates not tested","Several regulatory pathways validated in single labs"]},{"year":2013,"claim":"Live imaging showed APP and BACE1 are normally segregated and converge in recycling endosomes upon neuronal activity, and that BACE1 sheds Jagged1 to restrain Notch-driven astrogenesis, defining both spatial control of amyloidogenesis and a developmental role.","evidence":"Dendritic vesicle live imaging with clathrin inhibition; BACE1 KO/overexpression with Jag1 cleavage and neurogenesis/astrogenesis counts","pmids":["23931995","23831026"],"confidence":"High","gaps":["Trigger coupling activity to APP rerouting not fully defined","Jag1 cleavage site not mapped"]},{"year":2014,"claim":"Contactin-2 was added as a validated GPI-proximal substrate, and RTN3 was identified as a negative regulator of BACE1 activity, refining substrate scope and endogenous inhibition.","evidence":"Contactin-2 cleavage-site mutagenesis with surface biotinylation; RTN3 KO mice with APP processing and amyloid readouts","pmids":["24405708","25319692"],"confidence":"Medium","gaps":["Functional role of soluble contactin-2 not established","RTN3-BACE1 inhibitory mechanism not structurally defined"]},{"year":2015,"claim":"BACE1-APP interaction was mapped to recycling microdomains and synaptic compartments, the protective Icelandic APP mutation was shown to weaken this interaction, BACE1 was found enriched in synaptic vesicles, and Schwann-cell BACE1 was shown necessary for peripheral remyelination.","evidence":"Fluorescence complementation interaction assay with Icelandic mutant; synaptic vesicle isolation and proximity ligation; sciatic nerve transplantation between BACE1-null and WT","pmids":["26642089","26296617","25740511"],"confidence":"High","gaps":["Quantitative contribution of synaptic vs endosomal cleavage to total Aβ unclear","Schwann vs axonal NRG1 source contributions not fully apportioned"]},{"year":2015,"claim":"sAPPα was identified as an endogenous allosteric BACE1 inhibitor whose activity depends on a conformation lost in sAPPβ, revealing a product-level negative feedback on the protease.","evidence":"In vitro BACE1 inhibition with recombinant sAPPα and small-angle X-ray scattering comparison","pmids":["26401691"],"confidence":"Medium","gaps":["Allosteric site not confirmed by mutagenesis","In vivo relevance of inhibition not tested"]},{"year":2016,"claim":"USP8-mediated deubiquitination at Lys501 and autophagy-lysosomal turnover were defined as opposing arms controlling endosomal BACE1 retention versus degradation.","evidence":"USP8 RNAi with ubiquitination and substrate-processing assays; axonal autophagic vacuole imaging with Snapin overexpression in mutant APP neurons","pmids":["27302062","28028177"],"confidence":"Medium","gaps":["E3 ligase acting at Lys501 not identified","Each mechanism from single lab"]},{"year":2017,"claim":"Par3/aPKC phosphorylation of BACE1-Ser498 and p75-mediated co-localization defined phosphorylation-controlled retrograde and amyloidogenic trafficking of BACE1, with reduced Ser498 phosphorylation in AD brain.","evidence":"Par3/aPKC perturbation with phospho-Ser498 analysis and BACE1-PACS1 Co-IP; p75-BACE1 Co-IP with JNK inhibition in cortical neurons","pmids":["28946017","28869759"],"confidence":"Medium","gaps":["p75 finding rests on Co-IP and co-localization without reciprocal validation","Kinase specificity for Ser498 across pathways not reconciled"]},{"year":2019,"claim":"MMP13 was shown to control BACE1 translationally via PI3K/eIF4B and the BACE1 5'UTR, adding a translational regulatory node with in vivo amyloid impact.","evidence":"Promoter/5'UTR luciferase screen, eIF4B S422R mutagenesis, 5'UTR deletion, and Mmp13 knockdown in APP/PS1 mice","pmids":["30596903"],"confidence":"Medium","gaps":["How MMP13 signals to PI3K not defined","Single lab"]},{"year":2020,"claim":"AP-2 was established as the adaptor routing internalized BACE1 to lysosomes, with genetic rescue confirming BACE1 as the causal amyloidogenic node downstream of AP-2 loss.","evidence":"Conditional AP-2 KO mice and iPSC AD neurons with BACE1-deletion genetic rescue","pmids":["32323475"],"confidence":"High","gaps":["Direct AP-2 recognition motif on BACE1 not defined","Relationship to the di-leucine lysosomal motif not reconciled"]},{"year":2021,"claim":"BACE1 was shown to be required for synaptic vesicle docking and LTP via mGluR1, and Rab35/OCRL was identified as sorting BACE1 out of the amyloidogenic endosomal route.","evidence":"BACE1 KO and inhibitors with EM vesicle docking, LTP, behavior, and mGluR1 PAM rescue; Rab35 overexpression/knockdown with OCRL/ACAP2 effector studies","pmids":["34158621","34876559"],"confidence":"High","gaps":["Substrate cleavage event linking BACE1 to vesicle docking not identified","How mGluR1 levels depend on BACE1 unclear"]},{"year":2022,"claim":"Cell-type-specific deletion revealed microglial BACE1 restrains protective phagocytic and disease-associated microglial programs by cleaving IL-1R2 and Toll-like receptors, repositioning BACE1 as an immune regulator in amyloid clearance.","evidence":"Microglial Bace1 deletion in 5xFAD mice with scRNA-seq, phagocytosis and signaling assays, plaque and LTP readouts","pmids":["35857844","35714196"],"confidence":"High","gaps":["Direct cleavage of IL-1R2/TLRs not mapped at residue level","Translation to non-5xFAD contexts untested"]},{"year":2023,"claim":"Astrocytic BACE1 was shown to cleave insulin receptors, and its deletion enhances Clusterin-dependent Aβ clearance, defining a glial substrate-to-clearance axis.","evidence":"Astrocyte-specific Bace1 KO in 5xFAD with scRNA-seq, siRNA, Aβ uptake/degradation, and plaque quantification","pmids":["37143090"],"confidence":"High","gaps":["Insulin receptor cleavage site not mapped","Direct Clusterin regulation mechanism downstream of IR signaling not fully defined"]},{"year":2006,"claim":"BACE1 dimerization was proposed as a determinant of catalytic activity, raising the question of how oligomeric state shapes function.","evidence":"Biochemical dimerization and active-site mutagenesis analysis of human brain BACE1","pmids":["17047367"],"confidence":"Low","gaps":["Limited mechanistic detail and single study","Functional consequence of dimerization not independently confirmed"]},{"year":null,"claim":"How the many trafficking, transcriptional, translational, and post-translational regulators integrate to set BACE1 activity at specific membranes, and which substrate cleavages mediate its non-amyloid synaptic and glial functions, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Substrates linking BACE1 to vesicle docking and LTP unidentified","Cleavage sites for several glial/immune substrates unmapped","Integration of competing trafficking regulators not reconciled into a unified model"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2,8,11,19,30]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[8,19,31]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[12,13,14,23,34,35]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[4,16,26]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,19,30]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[17,12]}],"pathway":[{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[12,13,26,32]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[8,19,4,5]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,10,6,30]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[28,29]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,11,25]}],"complexes":[],"partners":["APP","NRG1","GGA3","USP8","RTN3","SNX12","PACS1","SUMO1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P56817","full_name":"Beta-secretase 1","aliases":["Aspartyl protease 2","ASP2","Asp 2","Beta-site amyloid precursor protein cleaving enzyme 1","Beta-site APP cleaving enzyme 1","Memapsin-2","Membrane-associated aspartic protease 2"],"length_aa":501,"mass_kda":55.8,"function":"Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves at the N-terminus of the A-beta peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C-terminal fragment which is later released by gamma-secretase (PubMed:10656250, PubMed:10677483, PubMed:20354142). Cleaves CHL1 (By similarity)","subcellular_location":"Cell membrane; Golgi apparatus, trans-Golgi network; Endoplasmic reticulum; Endosome; Cell surface; Cytoplasmic vesicle membrane; Membrane raft; Lysosome; Late endosome; Early endosome; Recycling endosome; Cell projection, axon; Cell projection, dendrite","url":"https://www.uniprot.org/uniprotkb/P56817/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BACE1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BACE1","total_profiled":1310},"omim":[{"mim_id":"617084","title":"TRANSMEMBRANE PROTEIN 59; TMEM59","url":"https://www.omim.org/entry/617084"},{"mim_id":"616953","title":"CUTA DIVALENT CATION TOLERANCE HOMOLOG; CUTA","url":"https://www.omim.org/entry/616953"},{"mim_id":"615977","title":"MICRO RNA 339; MIR339","url":"https://www.omim.org/entry/615977"},{"mim_id":"614263","title":"BACE1 ANTISENSE RNA: BACE1AS","url":"https://www.omim.org/entry/614263"},{"mim_id":"610869","title":"LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 3; LRRTM3","url":"https://www.omim.org/entry/610869"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":113.1},{"tissue":"pancreas","ntpm":243.6}],"url":"https://www.proteinatlas.org/search/BACE1"},"hgnc":{"alias_symbol":["Asp2"],"prev_symbol":["BACE"]},"alphafold":{"accession":"P56817","domains":[{"cath_id":"2.40.70.10","chopping":"74-207","consensus_level":"medium","plddt":97.2682,"start":74,"end":207},{"cath_id":"2.40.70.10","chopping":"241-448","consensus_level":"medium","plddt":96.4984,"start":241,"end":448}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P56817","model_url":"https://alphafold.ebi.ac.uk/files/AF-P56817-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P56817-F1-predicted_aligned_error_v6.png","plddt_mean":87.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BACE1","jax_strain_url":"https://www.jax.org/strain/search?query=BACE1"},"sequence":{"accession":"P56817","fasta_url":"https://rest.uniprot.org/uniprotkb/P56817.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P56817/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P56817"}},"corpus_meta":[{"pmid":"17099708","id":"PMC_17099708","title":"Bace1 modulates myelination in the central and peripheral nervous system.","date":"2006","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17099708","citation_count":482,"is_preprint":false},{"pmid":"23202730","id":"PMC_23202730","title":"Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes.","date":"2012","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/23202730","citation_count":379,"is_preprint":false},{"pmid":"15987683","id":"PMC_15987683","title":"Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15987683","citation_count":297,"is_preprint":false},{"pmid":"17553422","id":"PMC_17553422","title":"Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity.","date":"2007","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/17553422","citation_count":292,"is_preprint":false},{"pmid":"22728825","id":"PMC_22728825","title":"Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons.","date":"2012","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22728825","citation_count":274,"is_preprint":false},{"pmid":"11525745","id":"PMC_11525745","title":"Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts.","date":"2001","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/11525745","citation_count":259,"is_preprint":false},{"pmid":"17576410","id":"PMC_17576410","title":"BACE1 regulates voltage-gated sodium channels and neuronal activity.","date":"2007","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17576410","citation_count":255,"is_preprint":false},{"pmid":"18385378","id":"PMC_18385378","title":"Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18385378","citation_count":234,"is_preprint":false},{"pmid":"23931995","id":"PMC_23931995","title":"Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway.","date":"2013","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/23931995","citation_count":190,"is_preprint":false},{"pmid":"12453676","id":"PMC_12453676","title":"Beta-secretase (BACE) as a drug target for Alzheimer's disease.","date":"2002","source":"Advanced drug delivery reviews","url":"https://pubmed.ncbi.nlm.nih.gov/12453676","citation_count":173,"is_preprint":false},{"pmid":"15059975","id":"PMC_15059975","title":"Gene structure and organization of the human beta-secretase (BACE) promoter.","date":"2004","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/15059975","citation_count":166,"is_preprint":false},{"pmid":"21543615","id":"PMC_21543615","title":"BACE1 activity is modulated by cell-associated sphingosine-1-phosphate.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21543615","citation_count":155,"is_preprint":false},{"pmid":"11816789","id":"PMC_11816789","title":"The beta-secretase, BACE: a prime drug target for Alzheimer's disease.","date":"2001","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/11816789","citation_count":154,"is_preprint":false},{"pmid":"22306812","id":"PMC_22306812","title":"Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22306812","citation_count":147,"is_preprint":false},{"pmid":"30224383","id":"PMC_30224383","title":"The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease.","date":"2018","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30224383","citation_count":147,"is_preprint":false},{"pmid":"26642089","id":"PMC_26642089","title":"Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway.","date":"2015","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26642089","citation_count":145,"is_preprint":false},{"pmid":"16033761","id":"PMC_16033761","title":"BACE is degraded via the lysosomal pathway.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16033761","citation_count":144,"is_preprint":false},{"pmid":"15289451","id":"PMC_15289451","title":"Degradation of BACE by the ubiquitin-proteasome pathway.","date":"2004","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/15289451","citation_count":135,"is_preprint":false},{"pmid":"14600149","id":"PMC_14600149","title":"BACE1 suppression by RNA interference in primary cortical neurons.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14600149","citation_count":130,"is_preprint":false},{"pmid":"15857888","id":"PMC_15857888","title":"Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes.","date":"2005","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/15857888","citation_count":118,"is_preprint":false},{"pmid":"28739891","id":"PMC_28739891","title":"BACE inhibition-dependent repair of Alzheimer's pathophysiology.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28739891","citation_count":110,"is_preprint":false},{"pmid":"25599931","id":"PMC_25599931","title":"Pharmacological inhibition of BACE1 impairs synaptic plasticity and cognitive functions.","date":"2014","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25599931","citation_count":108,"is_preprint":false},{"pmid":"21576249","id":"PMC_21576249","title":"Cleavage of neuregulin-1 by BACE1 or ADAM10 protein produces differential effects on myelination.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21576249","citation_count":101,"is_preprint":false},{"pmid":"30893882","id":"PMC_30893882","title":"BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer's Disease.","date":"2019","source":"Pharmaceuticals (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/30893882","citation_count":98,"is_preprint":false},{"pmid":"22002808","id":"PMC_22002808","title":"Amyloid-β production: major link between oxidative stress and BACE1.","date":"2011","source":"Neurotoxicity research","url":"https://pubmed.ncbi.nlm.nih.gov/22002808","citation_count":98,"is_preprint":false},{"pmid":"31661331","id":"PMC_31661331","title":"Investigational BACE inhibitors for the treatment of Alzheimer's disease.","date":"2019","source":"Expert opinion on investigational drugs","url":"https://pubmed.ncbi.nlm.nih.gov/31661331","citation_count":97,"is_preprint":false},{"pmid":"28749667","id":"PMC_28749667","title":"BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's Disease.","date":"2017","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28749667","citation_count":97,"is_preprint":false},{"pmid":"26696252","id":"PMC_26696252","title":"Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors.","date":"2016","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26696252","citation_count":94,"is_preprint":false},{"pmid":"28855981","id":"PMC_28855981","title":"Role of BACE1 in Alzheimer's synaptic function.","date":"2017","source":"Translational neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/28855981","citation_count":93,"is_preprint":false},{"pmid":"21371311","id":"PMC_21371311","title":"Differential regulation of BACE1 expression by oxidative and nitrosative signals.","date":"2011","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/21371311","citation_count":93,"is_preprint":false},{"pmid":"12065613","id":"PMC_12065613","title":"A non-amyloidogenic function of BACE-2 in the secretory pathway.","date":"2002","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12065613","citation_count":93,"is_preprint":false},{"pmid":"26710318","id":"PMC_26710318","title":"miR-186 is decreased in aged brain and suppresses BACE1 expression.","date":"2016","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26710318","citation_count":91,"is_preprint":false},{"pmid":"22926063","id":"PMC_22926063","title":"BACE1 in Alzheimer's disease.","date":"2012","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22926063","citation_count":76,"is_preprint":false},{"pmid":"11168415","id":"PMC_11168415","title":"Ligand binding and physico-chemical properties of ASP2, a recombinant odorant-binding protein from honeybee (Apis mellifera L.).","date":"2001","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11168415","citation_count":72,"is_preprint":false},{"pmid":"35119166","id":"PMC_35119166","title":"BACE1: More than just a β-secretase.","date":"2022","source":"Obesity reviews : an official journal of the International Association for the Study of Obesity","url":"https://pubmed.ncbi.nlm.nih.gov/35119166","citation_count":70,"is_preprint":false},{"pmid":"19429494","id":"PMC_19429494","title":"Function, regulation and therapeutic properties of beta-secretase (BACE1).","date":"2009","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19429494","citation_count":70,"is_preprint":false},{"pmid":"23831026","id":"PMC_23831026","title":"BACE1 regulates hippocampal astrogenesis via the Jagged1-Notch pathway.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/23831026","citation_count":66,"is_preprint":false},{"pmid":"30959172","id":"PMC_30959172","title":"BACE1-AS prevents BACE1 mRNA degradation through the sequestration of BACE1-targeting miRNAs.","date":"2019","source":"Journal of chemical neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/30959172","citation_count":65,"is_preprint":false},{"pmid":"22455478","id":"PMC_22455478","title":"BACE1 dependent neuregulin processing: review.","date":"2012","source":"Current Alzheimer research","url":"https://pubmed.ncbi.nlm.nih.gov/22455478","citation_count":64,"is_preprint":false},{"pmid":"26296617","id":"PMC_26296617","title":"ADAM10 and BACE1 are localized to synaptic vesicles.","date":"2015","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26296617","citation_count":64,"is_preprint":false},{"pmid":"35857844","id":"PMC_35857844","title":"Targeted BACE-1 inhibition in microglia enhances amyloid clearance and improved cognitive performance.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/35857844","citation_count":62,"is_preprint":false},{"pmid":"24550686","id":"PMC_24550686","title":"Icariin decreases the expression of APP and BACE-1 and reduces the β-amyloid burden in an APP transgenic mouse model of Alzheimer's disease.","date":"2014","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24550686","citation_count":62,"is_preprint":false},{"pmid":"19292866","id":"PMC_19292866","title":"Cell biology, regulation and inhibition of beta-secretase (BACE-1).","date":"2009","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/19292866","citation_count":61,"is_preprint":false},{"pmid":"27302062","id":"PMC_27302062","title":"The Endosome-associated Deubiquitinating Enzyme USP8 Regulates BACE1 Enzyme Ubiquitination and Degradation.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27302062","citation_count":61,"is_preprint":false},{"pmid":"30709653","id":"PMC_30709653","title":"New evolutions in the BACE1 inhibitor field from 2014 to 2018.","date":"2019","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/30709653","citation_count":61,"is_preprint":false},{"pmid":"28028177","id":"PMC_28028177","title":"Autophagy-mediated Regulation of BACE1 Protein Trafficking and Degradation.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28028177","citation_count":60,"is_preprint":false},{"pmid":"26912421","id":"PMC_26912421","title":"Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26912421","citation_count":60,"is_preprint":false},{"pmid":"29106038","id":"PMC_29106038","title":"The physical approximation of APP and BACE-1: A key event in alzheimer's disease pathogenesis.","date":"2017","source":"Developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/29106038","citation_count":59,"is_preprint":false},{"pmid":"21897006","id":"PMC_21897006","title":"Amyloid-β₄₂ activates the expression of BACE1 through the JNK pathway.","date":"2011","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/21897006","citation_count":54,"is_preprint":false},{"pmid":"25319692","id":"PMC_25319692","title":"Impact of RTN3 deficiency on expression of BACE1 and amyloid deposition.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25319692","citation_count":53,"is_preprint":false},{"pmid":"27138913","id":"PMC_27138913","title":"Neuronal human BACE1 knockin induces systemic diabetes in mice.","date":"2016","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/27138913","citation_count":53,"is_preprint":false},{"pmid":"19898803","id":"PMC_19898803","title":"Cholinesterase and BACE1 inhibitory diterpenoids from Aralia cordata.","date":"2009","source":"Archives of pharmacal research","url":"https://pubmed.ncbi.nlm.nih.gov/19898803","citation_count":52,"is_preprint":false},{"pmid":"20817005","id":"PMC_20817005","title":"BACE: Therapeutic target and potential biomarker for Alzheimer's disease.","date":"2010","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/20817005","citation_count":51,"is_preprint":false},{"pmid":"35714196","id":"PMC_35714196","title":"BACE-1 inhibition facilitates the transition from homeostatic microglia to DAM-1.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/35714196","citation_count":51,"is_preprint":false},{"pmid":"18374657","id":"PMC_18374657","title":"Impact of cholesterol level upon APP and BACE proximity and APP cleavage.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18374657","citation_count":51,"is_preprint":false},{"pmid":"22975420","id":"PMC_22975420","title":"SUMO1 modulates Aβ generation via BACE1 accumulation.","date":"2012","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/22975420","citation_count":51,"is_preprint":false},{"pmid":"12815710","id":"PMC_12815710","title":"Cloning and expression of the rat BACE1 promoter.","date":"2003","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/12815710","citation_count":48,"is_preprint":false},{"pmid":"30596903","id":"PMC_30596903","title":"MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation.","date":"2019","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/30596903","citation_count":47,"is_preprint":false},{"pmid":"16712492","id":"PMC_16712492","title":"Human beta-secretase (BACE) and BACE inhibitors: progress report.","date":"2006","source":"Current topics in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16712492","citation_count":46,"is_preprint":false},{"pmid":"32323475","id":"PMC_32323475","title":"AP-2 reduces amyloidogenesis by promoting BACE1 trafficking and degradation in neurons.","date":"2020","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/32323475","citation_count":46,"is_preprint":false},{"pmid":"19196715","id":"PMC_19196715","title":"Mutant presenilin 1 increases the expression and activity of BACE1.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19196715","citation_count":46,"is_preprint":false},{"pmid":"22709416","id":"PMC_22709416","title":"Sorting nexin 12 interacts with BACE1 and regulates BACE1-mediated APP processing.","date":"2012","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/22709416","citation_count":45,"is_preprint":false},{"pmid":"21403391","id":"PMC_21403391","title":"BACE1 as a potential biomarker for Alzheimer's disease.","date":"2011","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/21403391","citation_count":45,"is_preprint":false},{"pmid":"26401691","id":"PMC_26401691","title":"sAβPPα is a Potent Endogenous Inhibitor of BACE1.","date":"2015","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/26401691","citation_count":45,"is_preprint":false},{"pmid":"31570097","id":"PMC_31570097","title":"The effect of BACE1-AS on β-amyloid generation by regulating BACE1 mRNA expression.","date":"2019","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31570097","citation_count":44,"is_preprint":false},{"pmid":"29945719","id":"PMC_29945719","title":"Consequences of Pharmacological BACE Inhibition on Synaptic Structure and Function.","date":"2018","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/29945719","citation_count":43,"is_preprint":false},{"pmid":"24405708","id":"PMC_24405708","title":"BACE1 activity regulates cell surface contactin-2 levels.","date":"2014","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/24405708","citation_count":43,"is_preprint":false},{"pmid":"25300425","id":"PMC_25300425","title":"BACE1 and cholinesterase inhibitory activities of Nelumbo nucifera embryos.","date":"2014","source":"Archives of pharmacal research","url":"https://pubmed.ncbi.nlm.nih.gov/25300425","citation_count":41,"is_preprint":false},{"pmid":"15958191","id":"PMC_15958191","title":"Biochemical and cell-based assays for characterization of BACE-1 inhibitors.","date":"2005","source":"Analytical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15958191","citation_count":41,"is_preprint":false},{"pmid":"17325690","id":"PMC_17325690","title":"Receptor tyrosine kinases positively regulate BACE activity and Amyloid-beta production through enhancing BACE internalization.","date":"2007","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/17325690","citation_count":39,"is_preprint":false},{"pmid":"12895444","id":"PMC_12895444","title":"BACE-2 is overexpressed in Down's syndrome.","date":"2003","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12895444","citation_count":39,"is_preprint":false},{"pmid":"20821260","id":"PMC_20821260","title":"IGF-1 reduces BACE-1 expression in PC12 cells via activation of PI3-K/Akt and MAPK/ERK1/2 signaling pathways.","date":"2010","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/20821260","citation_count":38,"is_preprint":false},{"pmid":"12618121","id":"PMC_12618121","title":"BACE1 and BACE2 in pathologic and normal human muscle.","date":"2003","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12618121","citation_count":37,"is_preprint":false},{"pmid":"29632166","id":"PMC_29632166","title":"BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29632166","citation_count":36,"is_preprint":false},{"pmid":"23036978","id":"PMC_23036978","title":"Lysophosphatidic acid induces increased BACE1 expression and Aβ formation.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23036978","citation_count":36,"is_preprint":false},{"pmid":"37143090","id":"PMC_37143090","title":"BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of β-amyloid peptides.","date":"2023","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/37143090","citation_count":34,"is_preprint":false},{"pmid":"34158621","id":"PMC_34158621","title":"BACE1 controls synaptic function through modulating release of synaptic vesicles.","date":"2021","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/34158621","citation_count":34,"is_preprint":false},{"pmid":"33862517","id":"PMC_33862517","title":"Synthesis and evaluation of multi-target-directed ligands with BACE-1 inhibitory and Nrf2 agonist activities as potential agents against Alzheimer's disease.","date":"2021","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33862517","citation_count":34,"is_preprint":false},{"pmid":"27023706","id":"PMC_27023706","title":"Future Therapeutics in Alzheimer's Disease: Development Status of BACE Inhibitors.","date":"2016","source":"BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/27023706","citation_count":33,"is_preprint":false},{"pmid":"25740511","id":"PMC_25740511","title":"Axonal and Schwann cell BACE1 is equally required for remyelination of peripheral nerves.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25740511","citation_count":33,"is_preprint":false},{"pmid":"19760173","id":"PMC_19760173","title":"BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis.","date":"2009","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/19760173","citation_count":31,"is_preprint":false},{"pmid":"28869548","id":"PMC_28869548","title":"Polymethoxyflavones: Novel β-Secretase (BACE1) Inhibitors from Citrus Peels.","date":"2017","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/28869548","citation_count":31,"is_preprint":false},{"pmid":"24739782","id":"PMC_24739782","title":"Occludin deficiency with BACE1 elevation in cerebral amyloid angiopathy.","date":"2014","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24739782","citation_count":30,"is_preprint":false},{"pmid":"36265268","id":"PMC_36265268","title":"Guanidine-based β amyloid precursor protein cleavage enzyme 1 (BACE-1) inhibitors for the Alzheimer's disease (AD): A review.","date":"2022","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36265268","citation_count":29,"is_preprint":false},{"pmid":"28157093","id":"PMC_28157093","title":"BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants.","date":"2017","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/28157093","citation_count":27,"is_preprint":false},{"pmid":"22885294","id":"PMC_22885294","title":"The accessory Sec protein Asp2 modulates GlcNAc deposition onto the serine-rich repeat glycoprotein GspB.","date":"2012","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/22885294","citation_count":26,"is_preprint":false},{"pmid":"28869759","id":"PMC_28869759","title":"p75 neurotrophin receptor interacts with and promotes BACE1 localization in endosomes aggravating amyloidogenesis.","date":"2017","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28869759","citation_count":26,"is_preprint":false},{"pmid":"28946017","id":"PMC_28946017","title":"Par3 and aPKC regulate BACE1 endosome-to-TGN trafficking through PACS1.","date":"2017","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/28946017","citation_count":25,"is_preprint":false},{"pmid":"30657591","id":"PMC_30657591","title":"The β-secretase (BACE) inhibitor NB-360 in preclinical models: From amyloid-β reduction to downstream disease-relevant effects.","date":"2019","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30657591","citation_count":25,"is_preprint":false},{"pmid":"31416794","id":"PMC_31416794","title":"Multiple BACE1 inhibitors abnormally increase the BACE1 protein level in neurons by prolonging its half-life.","date":"2019","source":"Alzheimer's & dementia : the journal of the Alzheimer's Association","url":"https://pubmed.ncbi.nlm.nih.gov/31416794","citation_count":24,"is_preprint":false},{"pmid":"34876559","id":"PMC_34876559","title":"Rab35 and glucocorticoids regulate APP and BACE1 trafficking to modulate Aβ production.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34876559","citation_count":23,"is_preprint":false},{"pmid":"21531800","id":"PMC_21531800","title":"Asp2 and Asp3 interact directly with GspB, the export substrate of the Streptococcus gordonii accessory Sec System.","date":"2011","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/21531800","citation_count":23,"is_preprint":false},{"pmid":"18509066","id":"PMC_18509066","title":"Mutational analysis of the conserved Asp2.50 and ERY motif reveals signaling bias of the urotensin II receptor.","date":"2008","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18509066","citation_count":22,"is_preprint":false},{"pmid":"27511641","id":"PMC_27511641","title":"β-Secretase (BACE1) inhibitory and neuroprotective effects of p-terphenyls from Polyozellus multiplex.","date":"2016","source":"Food & function","url":"https://pubmed.ncbi.nlm.nih.gov/27511641","citation_count":22,"is_preprint":false},{"pmid":"30927588","id":"PMC_30927588","title":"Semi-synthetic isoflavones as BACE-1 inhibitors against Alzheimer's disease.","date":"2019","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30927588","citation_count":22,"is_preprint":false},{"pmid":"11152138","id":"PMC_11152138","title":"The amino terminus of PKA catalytic subunit--a site for introduction of posttranslational heterogeneities by deamidation: D-Asp2 and D-isoAsp2 containing isozymes.","date":"2000","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/11152138","citation_count":22,"is_preprint":false},{"pmid":"17047367","id":"PMC_17047367","title":"Amyloid precursor protein and BACE function as oligomers.","date":"2006","source":"Neuro-degenerative diseases","url":"https://pubmed.ncbi.nlm.nih.gov/17047367","citation_count":21,"is_preprint":false},{"pmid":"36361906","id":"PMC_36361906","title":"Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer's Disease: From In Silico to In Vivo.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36361906","citation_count":21,"is_preprint":false},{"pmid":"36509631","id":"PMC_36509631","title":"Unmasking BACE1 in aging and age-related diseases.","date":"2022","source":"Trends in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36509631","citation_count":20,"is_preprint":false},{"pmid":"24081378","id":"PMC_24081378","title":"Can BACE1 inhibition mitigate early axonal pathology in neurological diseases?","date":"2014","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/24081378","citation_count":20,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49101,"output_tokens":10021,"usd":0.148809,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20295,"output_tokens":6572,"usd":0.132887,"stage2_stop_reason":"end_turn"},"total_usd":0.281696,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"BACE1 cleaves neuregulin-1 (NRG1) in the CNS and PNS; genetic deletion of Bace1 in mice causes hypomyelination, delays myelination, reduces myelin sheath thickness, and decreases phosphorylated Akt in myelin-forming cells, with full-length NRG1 accumulating and its cleavage product reduced in null mice, establishing BACE1-mediated NRG1 processing as a regulator of myelination via the neuregulin-Akt signaling pathway.\",\n      \"method\": \"Bace1 knockout mice, western blotting, neurological behavioral assays, immunohistochemistry\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular phenotype, biochemical readout of substrate accumulation and downstream signaling, independently replicated in subsequent studies\",\n      \"pmids\": [\"17099708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GGA3 (an adaptor protein involved in BACE1 trafficking) controls BACE1 protein stability post-translationally; RNAi depletion of GGA3 elevates BACE1 levels and beta-secretase activity via caspase-activated posttranslational stabilization of BACE1, and GGA3 levels are inversely correlated with BACE1 levels in AD brain and following cerebral ischemia.\",\n      \"method\": \"RNAi knockdown, western blotting, caspase inhibition, AD brain samples, cerebral ischemia model\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — RNAi with defined biochemical phenotype, multiple orthogonal methods (cell lines, ischemia model, human brain), mechanistic follow-up with caspase activation\",\n      \"pmids\": [\"17553422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BACE1 cleaves the voltage-gated sodium channel beta2-subunit (Nav1 β2); BACE1-gamma-secretase sequential cleavage releases the β2 intracellular domain, which increases Nav1.1 alpha-subunit mRNA and protein, but Nav1.1 is retained intracellularly, reducing cell-surface sodium current densities in neuroblastoma cells and hippocampal neurons from BACE1-transgenic mice.\",\n      \"method\": \"BACE1-transgenic mice, neuroblastoma cell overexpression, electrophysiology (sodium current recordings), western blotting, mRNA quantification\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (overexpression, transgenic mice, electrophysiology, biochemical assays) in one study\",\n      \"pmids\": [\"17576410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"BACE1 (Asp2) is compartmentalized into low-buoyant density, non-caveolar lipid rafts; both BACE1 protein and activity co-fractionate with raft markers in three distinct cell lines by detergent and non-detergent methods, and cholesterol depletion abolishes this raft association.\",\n      \"method\": \"Density gradient fractionation (detergent and non-detergent), immunoisolation of caveolin-containing vesicles, cholesterol depletion, enzyme activity assays\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cell lines, orthogonal fractionation methods, cholesterol depletion functional validation\",\n      \"pmids\": [\"11525745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"BACE1 is degraded via the lysosomal pathway; lysosomal inhibitors (chloroquine, NH4Cl) cause accumulation of BACE1 in LAMP2-positive late endosomal/lysosomal compartments, and the di-leucine motif (LL499/500) in the BACE1 C-terminus is required for efficient lysosomal sorting, as the LL/AA mutant shows impaired co-localization with LAMP2-positive compartments.\",\n      \"method\": \"Lysosomal inhibitor treatment, site-directed mutagenesis (LL/AA), immunofluorescence co-localization, western blotting in multiple cell types including primary neurons\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mutagenesis of sorting motif, multiple cell types including neurons, orthogonal localization and biochemical methods\",\n      \"pmids\": [\"16033761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"BACE1 protein is ubiquitinated and degraded via the ubiquitin-proteasome pathway; proteasome inhibition (lactacystin) increases BACE1 protein levels in a time- and dose-dependent manner and elevates APP C99 production and Aβ generation.\",\n      \"method\": \"Proteasome inhibitor treatment (lactacystin), ubiquitination immunoprecipitation, western blotting, Aβ/C99 measurement\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, pharmacological inhibition plus ubiquitination IP, single method for ubiquitination\",\n      \"pmids\": [\"15289451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BACE1-dependent NRG1 processing regulates ErbB4 signaling; BACE1-null mice show reduced ErbB4-PSD95 interaction, decreased hippocampal dendritic spine density, and schizophrenia-like behaviors (impaired prepulse inhibition, hyperactivity, cognitive deficits), which are partially rescued by the antipsychotic clozapine, linking BACE1-NRG1/ErbB4 signaling to synaptic function and psychiatric phenotypes.\",\n      \"method\": \"BACE1 knockout mice, behavioral assays, co-immunoprecipitation (ErbB4-PSD95), dendritic spine quantification, pharmacological rescue with clozapine\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with multiple orthogonal readouts (behavioral, biochemical, morphological, pharmacological rescue), single lab\",\n      \"pmids\": [\"18385378\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GSK3β specifically (not GSK3α) regulates BACE1 gene transcription and expression via NF-κB signaling; specific inhibition of GSK3β reduces BACE1-mediated APP cleavage and Aβ production, decreases amyloid deposition, and rescues memory deficits in double-transgenic AD mice.\",\n      \"method\": \"Isoform-specific inhibition, NF-κB reporter assays, BACE1 transcription assays, transgenic AD mouse model, behavioral testing\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (transcription, cell-based, in vivo), single lab\",\n      \"pmids\": [\"23202730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BACE1 is a major neuronal sheddase; proteome-wide SPECS method identified 34 novel BACE1 substrates in primary neurons including seizure-protein 6, L1, CHL1, and contactin-2, validated in BACE1 inhibitor-treated and BACE1 knockout mouse brains, pointing to roles in neurite outgrowth and synapse formation.\",\n      \"method\": \"Metabolic glycan labeling, click chemistry-mediated biotinylation (SPECS), mass spectrometry, validation in BACE1 KO and inhibitor-treated mouse brains\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — novel proteomics method with in vivo genetic validation in KO mice and pharmacological inhibition, multiple substrates validated\",\n      \"pmids\": [\"22728825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Sphingosine-1-phosphate (S1P) directly binds full-length BACE1 and increases its proteolytic activity; inhibition of sphingosine kinase (SphK) or knockdown of SphK or overexpression of S1P-degrading enzymes decreases BACE1 activity and Aβ production in mouse neurons.\",\n      \"method\": \"Direct binding assay (S1P to BACE1), SphK inhibitor treatment, RNAi knockdown, overexpression of S1P-degrading enzymes, BACE1 activity assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding plus functional RNAi and pharmacological approaches, single lab\",\n      \"pmids\": [\"21543615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"BACE1 and ADAM10 cleave type I and III neuregulin-1 (Nrg1) at two adjacent sites (BACE1 site 8 amino acids downstream of ADAM10 site); both generate signaling-capable N-terminal fragments activating ErbB receptors (phosphorylated Akt and ERK), but specific inhibition of BACE1 (not ADAM10) impairs myelination in co-culture, indicating BACE1 cleavage of Nrg1 is specifically required for myelination.\",\n      \"method\": \"Cleavage site mapping, optimized electrophoresis, ErbB receptor phosphorylation assays, BACE1/ADAM10 inhibitor treatment, co-culture myelination assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — biochemical cleavage site mapping plus functional myelination assay with specific inhibitors, multiple orthogonal methods\",\n      \"pmids\": [\"21576249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BACE1 directly cleaves membrane-anchored Jagged1 (Jag1), reducing Jag1 shedding; in BACE1-null mice, reduced Jag1 shedding enhances Notch signaling via cell-cell juxtacrine interactions, leading to increased astrogenesis and decreased neurogenesis in the hippocampus during early development.\",\n      \"method\": \"BACE1 knockout mice, overexpression of BACE1, biochemical cleavage assays, cell counting (neurogenesis/astrogenesis), Notch signaling assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO plus overexpression with biochemical and cellular readouts, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"23831026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"APP and BACE-1 are largely segregated in distinct vesicles under physiological conditions in neurons (BACE-1 in acidic recycling endosomes; APP in Golgi-derived vesicles); neuronal activity triggers APP routing into BACE-1-positive recycling endosomes via a clathrin-dependent endocytic mechanism, enabling their convergence and amyloidogenic processing.\",\n      \"method\": \"Live imaging of dendritic APP/BACE-1-containing vesicles in hippocampal neurons, clathrin inhibition, subcellular fractionation, activity induction paradigms\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live-cell imaging with mechanistic perturbation (clathrin inhibition), multiple orthogonal approaches in single lab\",\n      \"pmids\": [\"23931995\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"APP and BACE-1 interact in both biosynthetic and endocytic compartments, particularly at recycling microdomains such as dendritic spines and presynaptic boutons; in axons, APP and BACE-1 are co-transported and interact during transit; the Alzheimer's disease-protective Icelandic mutation greatly attenuates APP-BACE-1 interaction.\",\n      \"method\": \"Fluorescence complementation optical assay for APP-BACE-1 interaction, endosomal fate-tracking assays in hippocampal neurons, Icelandic mutant APP analysis\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — novel in cellulo interaction assay with multiple complementary live-imaging approaches, genetic variant validation\",\n      \"pmids\": [\"26642089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"USP8, an endosome-associated deubiquitinating enzyme, deubiquitinates BACE1 at lysine 501, maintaining BACE1 in recycling endosomes; RNAi depletion of USP8 increases BACE1 ubiquitination, promotes BACE1 accumulation in early and late endosomes/lysosomes, reduces BACE1 levels, and decreases BACE1-mediated APP cleavage and Aβ generation.\",\n      \"method\": \"RNAi knockdown of USP8, ubiquitination assays, endosomal co-localization, western blotting, Aβ/sAPPβ measurement in H4 neuroglioma cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi with multiple orthogonal readouts (ubiquitination, localization, substrate processing), single lab\",\n      \"pmids\": [\"27302062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SUMO1 interacts with the dileucine motif of BACE1 and regulates BACE1 protein levels; altering SUMO1 (but not SUMO2 or SUMO3 alone) modulates BACE1 protein levels and consequently APP processing and Aβ generation; BACE1 levels increase in response to Aβ or apoptosis in a SUMO1-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation, gain/loss of function experiments, western blotting, Aβ measurement, APP transgenic mice\",\n      \"journal\": \"Neurobiology of aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP plus functional gain/loss experiments, single lab, multiple orthogonal approaches\",\n      \"pmids\": [\"22975420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Autophagy-lysosomal pathway regulates BACE1 trafficking and degradation; induction of neuronal autophagy enhances BACE1 turnover suppressible by lysosomal inhibition; BACE1 co-migrates with autophagic vacuoles along axons in a retrograde manner; in mutant APP transgenic neurons, autophagic vacuole-associated BACE1 accumulates in distal axons enhancing β-cleavage, and Snapin-enhanced retrograde transport restores BACE1 delivery to lysosomes.\",\n      \"method\": \"Live imaging of axonal transport, autophagy induction/inhibition, lysosomal inhibition, Snapin overexpression, mutant APP transgenic neurons and mice\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live imaging plus genetic and pharmacological perturbations, single lab\",\n      \"pmids\": [\"28028177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"BACE1 is highly enriched in synaptic vesicles isolated from rat brain; BACE1 localizes in close proximity to synaptic vesicle marker synaptophysin in intact hippocampal neurons as shown by proximity ligation assay, supporting BACE1-mediated APP processing at the synapse.\",\n      \"method\": \"Controlled-pore glass chromatography synaptic vesicle isolation, western blotting, proximity ligation assay in primary hippocampal neurons\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — subcellular fractionation plus in situ proximity assay, multiple orthogonal localization methods, single lab\",\n      \"pmids\": [\"26296617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Reticulon 3 (RTN3) interacts with BACE1 and negatively regulates its activity; RTN3-null mice show increased BACE1 protein levels, enhanced APP processing at the β-secretase site, and accelerated amyloid deposition in Alzheimer's mouse models.\",\n      \"method\": \"RTN3 knockout mice, western blotting, APP processing biochemical assays, amyloid plaque quantification in AD mouse models\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with biochemical and in vivo amyloid readouts, single lab\",\n      \"pmids\": [\"25319692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"BACE1 cleaves human contactin-2 at a site near its GPI membrane linker domain; BACE1 overexpression increases soluble contactin-2 in conditioned media, pharmacological BACE1 inhibition decreases it, and mutation of the BACE1 cleavage site (1008MM/AA) dramatically impairs contactin-2 shedding; BACE1 activity tightly regulates contactin-2 cell surface levels in CHO cells and primary neurons.\",\n      \"method\": \"BACE1 overexpression, pharmacological inhibition, cleavage site mutagenesis, immunofluorescence, surface biotinylation assays, conditioned media ELISA\",\n      \"journal\": \"Molecular neurodegeneration\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — mutagenesis of cleavage site plus multiple functional readouts (overexpression, inhibition, surface biotinylation), single lab\",\n      \"pmids\": [\"24405708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Oxidative stress increases BACE1 protein levels via the PKR-eIF2α pathway; specific inhibition of PKR-eIF2α signaling attenuates BACE1 protein levels under H2O2-induced oxidative stress in human neuroblastoma cells, and activated PKR, phospho-eIF2α, and BACE1 are co-elevated in AD cortices and APP/PS1 mice.\",\n      \"method\": \"Western blotting, PKR/eIF2α inhibitors, H2O2 treatment, human AD brain samples, APP/PS1 knock-in mice\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological pathway inhibition plus human tissue correlation, multiple model systems, single lab\",\n      \"pmids\": [\"22306812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NO differentially modulates BACE1: low concentrations (<100 nM NO) suppress BACE1 transcription via NO/cGMP-PKG signaling (likely through PGC-1α activation), while higher NO levels (0.1-100 μM) induce S-nitrosylation of BACE1 at cysteine residues, inactivating the enzyme without altering expression; H2O2 upregulates BACE1 expression via transcriptional activation.\",\n      \"method\": \"BACE1 activity assays, transcription assays, S-nitrosylation biochemistry, signaling pathway inhibitors (PKG inhibitor), cultured neurons\",\n      \"journal\": \"Molecular neurodegeneration\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple mechanistic experiments (transcription, post-translational modification, pathway inhibition), single lab\",\n      \"pmids\": [\"21371311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BACE1 regulates retrograde trafficking from endosomes to the TGN via Par3/aPKC-mediated phosphorylation of BACE1 at Ser498, which promotes BACE1-PACS1 interaction; in human AD brains, Ser498 phosphorylation of BACE1 is significantly decreased, suggesting defective retrograde transport contributes to BACE1 endosomal accumulation.\",\n      \"method\": \"Par3/aPKC overexpression and knockdown, BACE1 Ser498 phospho-specific analysis, co-immunoprecipitation (BACE1-PACS1), endosomal trafficking assays, human AD brain western blotting\",\n      \"journal\": \"Neurobiology of aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple molecular approaches (Co-IP, phospho-assays, trafficking assays, human tissue), single lab\",\n      \"pmids\": [\"28946017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Sorting nexin 12 (SNX12) interacts with BACE1 in early endosomes and regulates BACE1 endocytosis; SNX12 overexpression reduces Aβ, sAPPβ, and APP β-CTF without altering γ-secretase activity or in vitro BACE1 activity, while SNX12 downregulation increases BACE1 endocytosis and reduces cell surface BACE1.\",\n      \"method\": \"Co-immunoprecipitation (SNX12-BACE1), overexpression/knockdown, APP processing biochemical assays, endocytosis assays, human AD brain western blotting\",\n      \"journal\": \"Molecular neurodegeneration\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP plus functional gain/loss experiments, multiple readouts, single lab\",\n      \"pmids\": [\"22709416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BACE1 in human brain tissue occurs as a dimer, whereas the soluble ectodomain of truncated BACE1 occurs exclusively in monomeric form; mutational analysis of active sites suggests BACE1 may acquire specific catalytic activity upon oligomerization stabilized by transmembrane and cytoplasmic domains.\",\n      \"method\": \"Analysis of BACE1 in human brain tissue, truncation and active-site mutagenesis, biochemical dimerization analysis\",\n      \"journal\": \"Neuro-degenerative diseases\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single study, limited mechanistic detail in abstract, mutational analysis not fully described\",\n      \"pmids\": [\"17047367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"BACE1 in axons and Schwann cells is equally required for optimal remyelination of injured sciatic nerves; nerve injury induces BACE1 transcription and elevated BACE1 protein in Schwann cells, where type I (not type III) Nrg1 is induced, and abolished Nrg1 cleavage in BACE1-null Schwann cells contributes to impaired remyelination.\",\n      \"method\": \"Sciatic nerve segment transplantation (swapping between BACE1-null and wild-type), nerve injury models, western blotting, immunohistochemistry, BACE1 transcript quantification\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — elegant cell-type-specific transplantation experiment with defined substrate and cellular readouts, single lab\",\n      \"pmids\": [\"25740511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"AP-2 (protein complex-2 endocytic adaptor) prevents amyloidogenesis by regulating BACE1 endosomal trafficking and delivery to lysosomes downstream of BACE1 endocytosis; conditional AP-2 knockout mice show increased Aβ production due to BACE1 accumulation in late endosomes/autophagosomes, and deletion of BACE1 in AP-2 KO neurons decreases amyloidogenesis and mitigates synapse loss.\",\n      \"method\": \"Conditional AP-2 KO mice, iPSC-derived AD patient neurons, western blotting, endosomal localization, Aβ measurement, genetic rescue (BACE1 deletion in AP-2 KO neurons)\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO plus genetic rescue, iPSC human neurons, multiple orthogonal readouts\",\n      \"pmids\": [\"32323475\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BACE1 is required for optimal synaptic vesicle release; BACE1 deficiency or inhibition decreases synaptic vesicle docking in active zones, reduces hippocampal LTP, and impairs learning; levels of mGluR1 are reduced in BACE1-null mice, and mGluR1 positive allosteric modulators rescue LTP and cognitive deficits caused by BACE1 deficiency or inhibition.\",\n      \"method\": \"BACE1 knockout mice, BACE1 inhibitors (Verubecestat, Lanabecestat), electrophysiology (LTP), electron microscopy (vesicle docking), behavioral testing, mGluR1 PAM pharmacological rescue\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO plus pharmacological inhibition, EM for vesicle docking, electrophysiology, behavioral rescue experiments\",\n      \"pmids\": [\"34158621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Microglial BACE1 deficiency enhances Aβ clearance (not by reducing APP processing) by increasing a phagocytic microglial gene signature and enhancing autophagolysosome function; BACE1 deletion in microglia activates PI3K-mTOR-HIF-1α signaling (mTOR phosphorylated at Ser2448) and abolishes cleavage of IL-1R2 and Toll-like receptors, contributing to enhanced phagocytic signaling via PI3K and p38 MAPK.\",\n      \"method\": \"Microglial-specific Bace1 deletion in 5xFAD mice, scRNA-seq, amyloid plaque quantification, LTP measurement, in vitro BACE1 silencing/inhibition in microglia-derived cells, phagocytosis assays\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific KO, scRNA-seq, multiple functional assays (phagocytosis, LTP, signaling pathway), single lab with multiple orthogonal methods\",\n      \"pmids\": [\"35857844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"BACE1 deficiency in microglia facilitates their transition from homeostatic to stage 1 disease-associated microglia (DAM-1) by elevating transcription factors (Jun, Jund, Btg2, Erg1, Junb, Fos, Fosb); abolished cleavage of IL-1R2 and Toll-like receptors by BACE1 inhibition contributes to enhanced PI3K and p38 MAPK signaling.\",\n      \"method\": \"Targeted Bace1 deletion in adult 5xFAD microglia, scRNA-seq of purified microglia, BACE1 pharmacological inhibition in microglia-derived cells, amyloid plaque quantification\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO, scRNA-seq, pharmacological validation, multiple signaling pathway readouts\",\n      \"pmids\": [\"35714196\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BACE1 in astrocytes cleaves insulin receptors (IR) on the astrocyte surface; BACE1 deficiency abolishes IR cleavage, enhancing insulin receptor pathway signaling and upregulating Clusterin (CLU) and Cxcl14 expression; elevated astrocytic CLU enhances Aβ uptake and degradation, and astrocyte-specific BACE1 knockout in 5xFAD mice significantly reduces cortical amyloid plaque load.\",\n      \"method\": \"Astrocyte-specific Bace1 KO (Bace1fl/fl;Gfap-cre), scRNA-seq of purified astrocytes, siRNA knockdown, western blotting, Aβ uptake/degradation assays, amyloid plaque quantification\",\n      \"journal\": \"Molecular neurodegeneration\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific KO, scRNA-seq, mechanistic substrate identification (IR), siRNA rescue, in vivo plaque quantification\",\n      \"pmids\": [\"37143090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"sAPPα (the product of α-secretase cleavage of AβPP) is a potent endogenous direct inhibitor of BACE1, likely by an allosteric mechanism; sAPPβ (differing only by a 16-amino acid C-terminal truncation) adopts a structurally distinct conformation by small-angle X-ray scattering and does not inhibit BACE1.\",\n      \"method\": \"In vitro BACE1 inhibition assay with recombinant sAPPα, small-angle X-ray scattering (structural comparison of sAPPα vs sAPPβ)\",\n      \"journal\": \"Journal of Alzheimer's disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro enzyme assay with structural validation, single lab, no mutagenesis to confirm allosteric site\",\n      \"pmids\": [\"26401691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Mutant presenilin 1 (PS1) increases BACE1 expression and activity; this upregulation requires gamma-secretase cleavage of APP and is proportional to secreted Aβ42 (not AICD), identifying Aβ42 as the APP derivative that mediates PS1 mutation-induced BACE1 overexpression.\",\n      \"method\": \"Transient and stable transfection with PS1 mutants, gamma-secretase inhibition, western blotting, BACE1 activity assays, PS1 mutant knock-in mice, human FAD brain tissue\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cell systems plus knock-in mice plus human tissue, gamma-secretase inhibition to parse mechanism, single lab\",\n      \"pmids\": [\"19196715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"p75 neurotrophin receptor interacts with BACE1, and this interaction is enhanced by Aβ; p75 promotes BACE1 and APP co-localization in early endosomes via JNK-mediated phosphorylation of APP-Thr668 and BACE1-Ser498, enhancing amyloidogenesis in cortical neurons.\",\n      \"method\": \"Co-immunoprecipitation (p75-BACE1), immunofluorescence co-localization, early endosome fractionation, JNK inhibition, cortical neuron cultures\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Co-IP plus co-localization, single lab, limited mechanistic depth in abstract\",\n      \"pmids\": [\"28869759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Receptor tyrosine kinase (RTK) stimulation (EGF, NGF receptors) enhances BACE activity and Aβ production by promoting BACE1 internalization into endosomes and Golgi; this enhancement requires Src family kinase activity and endosomal internalization (Rab5-dependent), and is abolished by dominant-negative Rab5 or Src inhibitors.\",\n      \"method\": \"RTK stimulation (EGF, NGF), Src inhibitors, Src RNAi, dominant-negative Rab5, BACE1 activity assays, Aβ measurement, mouse hippocampus experiments\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple perturbations (pharmacological, genetic, dominant-negative) with in vitro and in vivo readouts, single lab\",\n      \"pmids\": [\"17325690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Rab35 negatively regulates Aβ production by sorting APP and BACE1 out of the endosomal network via distinct effectors: OCRL mediates BACE1 trafficking and ACAP2 mediates APP trafficking; Rab35 overexpression prevents amyloidogenic trafficking of APP and BACE1 induced by high glucocorticoid levels.\",\n      \"method\": \"Rab35 overexpression/knockdown, effector (OCRL, ACAP2) studies, APP/BACE1 endosomal trafficking assays, Aβ measurement, glucocorticoid treatment\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — overexpression/knockdown with defined effectors, multiple trafficking readouts, single lab\",\n      \"pmids\": [\"34876559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Aβ42 activates BACE1 gene transcription through the JNK/c-jun signaling pathway, creating a positive feedback loop; Aβ40 has much less effect on BACE1 expression.\",\n      \"method\": \"Aβ42/Aβ40 treatment of neuronal cells, BACE1 transcription assays, JNK pathway inhibition\",\n      \"journal\": \"Journal of Alzheimer's disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological pathway inhibition with transcription readout, specificity shown by Aβ40 vs Aβ42 comparison, single lab\",\n      \"pmids\": [\"21897006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MMP13 regulates BACE1 protein levels post-transcriptionally through PI3K signaling and eIF4B-mediated translational control; eIF4B phosphorylation at Ser422 mediates MMP13's effect on BACE1, and deletion of the BACE1 5'UTR abolishes MMP13-mediated regulation; MMP13 inhibition reduces BACE1 levels and Aβ deposition in APP/PS1 AD mice.\",\n      \"method\": \"High-throughput BACE1 promoter/5'UTR luciferase screen, eIF4B mutagenesis (S422R), 5'UTR deletion, PI3K inhibition, APP/PS1 mouse hippocampal Mmp13 knockdown, Aβ quantification\",\n      \"journal\": \"Brain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal approaches (mutagenesis, deletion, pharmacological, in vivo KD), single lab\",\n      \"pmids\": [\"30596903\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BACE1 is a transmembrane aspartyl protease that functions as the rate-limiting β-secretase for APP cleavage and Aβ generation, and as a broad neuronal sheddase processing multiple substrates including neuregulin-1 (regulating myelination and ErbB/Akt signaling), Nav1 β2-subunit (controlling sodium channel surface expression), Jagged1 (regulating Notch-dependent neurogenesis/astrogenesis), contactin-2, and astrocytic insulin receptors; its activity is spatially regulated by endosomal trafficking controlled by GGA3, USP8, AP-2, SNX12, Par3/aPKC-mediated Ser498 phosphorylation, and Rab35, with lipid raft compartmentalization and lysosomal degradation via a di-leucine sorting motif, while its levels are regulated transcriptionally (via NF-κB/GSK3β, JNK/c-jun, NO/cGMP-PKG) and post-translationally (ubiquitination, SUMO1, S-nitrosylation, and autophagy-mediated turnover), and it is additionally required for synaptic vesicle docking and microglial DAM transition.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BACE1 is a membrane-anchored aspartyl protease that functions as the principal neuronal β-secretase and a broad sheddase, governing both amyloidogenic APP processing and the proteolytic regulation of diverse cell-surface and signaling proteins in the nervous system [#8, #12]. Beyond APP, BACE1 cleaves neuregulin-1 to drive ErbB/Akt signaling required for CNS and PNS myelination and remyelination after nerve injury [#0, #10, #25], processes the voltage-gated sodium channel β2-subunit to control Nav1.1 surface expression and sodium current [#2], sheds Jagged1 to restrain Notch-dependent astrogenesis and promote neurogenesis [#11], and cleaves contactin-2 and a wider set of neuronal substrates implicated in neurite outgrowth and synapse formation [#8, #19]; in non-neuronal cells it cleaves astrocytic insulin receptors to suppress Clusterin-mediated Aβ clearance [#30] and processes IL-1R2 and Toll-like receptors in microglia to restrain phagocytic disease-associated microglial signaling [#28, #29]. The enzyme's activity is set by its subcellular itinerary: BACE1 partitions into cholesterol-dependent lipid rafts [#3], converges with APP in acidic recycling endosomes upon neuronal activity for amyloidogenic cleavage [#12, #13], and is sorted for degradation through a C-terminal di-leucine motif to lysosomes and via autophagy [#4, #16]. This trafficking is controlled by an array of factors including the deubiquitinase USP8 (which stabilizes endosomal BACE1 via Lys501) [#14], the adaptors GGA3 and AP-2 [#1, #26], SNX12, Rab35, and Par3/aPKC-mediated Ser498 phosphorylation that promotes PACS1-dependent retrograde transport [#22, #23, #35]. BACE1 levels are further tuned transcriptionally through GSK3β/NF-κB and Aβ42-driven JNK/c-jun feedback, and post-translationally by ubiquitination, SUMO1, and S-nitrosylation [#5, #7, #21, #36]. Functionally, BACE1 is required for synaptic vesicle docking, hippocampal LTP, and learning, acting in part through mGluR1 [#27].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Establishing where BACE1 acts within the membrane explained how its activity could be spatially compartmentalized rather than uniformly distributed.\",\n      \"evidence\": \"Density gradient fractionation and cholesterol depletion across three cell lines\",\n      \"pmids\": [\"11525745\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not connect raft localization to a specific substrate cleavage event\", \"Mechanism of raft targeting not defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identifying a di-leucine sorting motif and lysosomal degradation route defined how cells set steady-state BACE1 levels post-translationally.\",\n      \"evidence\": \"Lysosomal inhibitors plus LL/AA mutagenesis and LAMP2 co-localization in multiple cell types including neurons\",\n      \"pmids\": [\"16033761\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the adaptors recognizing the motif\", \"Link to amyloid output not addressed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating BACE1-dependent neuregulin-1 cleavage uncovered a physiological role beyond amyloid, linking the protease to myelination through neuregulin-Akt signaling.\",\n      \"evidence\": \"Bace1 knockout mice with NRG1 fragment quantification, myelin morphology, and phospho-Akt readouts\",\n      \"pmids\": [\"17099708\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cleavage site not mapped in this study\", \"Did not distinguish neuronal vs glial source of cleavage\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showing GGA3 controls BACE1 stability and that BACE1 cleaves the Nav1 β2-subunit extended the enzyme's regulation and substrate repertoire into channel surface control and ischemic stress.\",\n      \"evidence\": \"GGA3 RNAi with caspase inhibition and AD/ischemia tissue; β2 cleavage with electrophysiology in transgenic mice\",\n      \"pmids\": [\"17553422\", \"17576410\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Caspase-cleaved GGA3 species not fully resolved\", \"Functional consequence of β2 cleavage in vivo for excitability untested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"RTK signaling was shown to acutely enhance BACE1 activity by driving its Rab5/Src-dependent endosomal internalization, tying receptor signaling to amyloidogenesis.\",\n      \"evidence\": \"EGF/NGF stimulation with Src inhibitors, Src RNAi, and dominant-negative Rab5\",\n      \"pmids\": [\"17325690\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct phosphorylation target linking RTK to BACE1 trafficking not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Linking BACE1-NRG1 processing to ErbB4-PSD95 signaling connected the protease to synaptic structure and psychiatric-relevant behavior.\",\n      \"evidence\": \"BACE1 KO mice with behavioral assays, ErbB4-PSD95 Co-IP, spine quantification, and clozapine rescue\",\n      \"pmids\": [\"18385378\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Only partial pharmacological rescue\", \"Causal chain from NRG1 fragment to spine loss not fully isolated\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identifying Aβ42 as the APP derivative driving PS1-mutation-induced BACE1 upregulation revealed a feed-forward link between γ-secretase products and β-secretase levels.\",\n      \"evidence\": \"PS1 mutant transfection and knock-in mice with γ-secretase inhibition and human FAD tissue\",\n      \"pmids\": [\"19196715\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Transcriptional vs post-translational basis not separated here\", \"Single lab\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Multiple regulatory inputs (S1P binding, NO/cGMP and S-nitrosylation, Aβ42/JNK feedback) were resolved, showing BACE1 activity and expression are tuned by lipids, redox state, and product feedback.\",\n      \"evidence\": \"Direct S1P binding and SphK perturbation; S-nitrosylation biochemistry with PKG inhibition; Aβ42 vs Aβ40 with JNK inhibition; NRG1 cleavage site mapping with myelination co-culture\",\n      \"pmids\": [\"21543615\", \"21371311\", \"21897006\", \"21576249\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"S1P binding site on BACE1 not mapped\", \"Concentration thresholds for NO effects from cell culture\", \"Each mechanism from a single lab\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Proteome-wide substrate discovery established BACE1 as a major neuronal sheddase with dozens of substrates, while SUMO1, GSK3β/NF-κB, and PKR-eIF2α regulation defined the modification and transcriptional control layers.\",\n      \"evidence\": \"SPECS proteomics with KO/inhibitor validation; SUMO1 Co-IP and gain/loss; GSK3β isoform-specific inhibition with AD mice; PKR-eIF2α inhibition under oxidative stress; SNX12 Co-IP and trafficking\",\n      \"pmids\": [\"22728825\", \"22975420\", \"23202730\", \"22306812\", \"22709416\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological function of most novel substrates not tested\", \"Several regulatory pathways validated in single labs\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Live imaging showed APP and BACE1 are normally segregated and converge in recycling endosomes upon neuronal activity, and that BACE1 sheds Jagged1 to restrain Notch-driven astrogenesis, defining both spatial control of amyloidogenesis and a developmental role.\",\n      \"evidence\": \"Dendritic vesicle live imaging with clathrin inhibition; BACE1 KO/overexpression with Jag1 cleavage and neurogenesis/astrogenesis counts\",\n      \"pmids\": [\"23931995\", \"23831026\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trigger coupling activity to APP rerouting not fully defined\", \"Jag1 cleavage site not mapped\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Contactin-2 was added as a validated GPI-proximal substrate, and RTN3 was identified as a negative regulator of BACE1 activity, refining substrate scope and endogenous inhibition.\",\n      \"evidence\": \"Contactin-2 cleavage-site mutagenesis with surface biotinylation; RTN3 KO mice with APP processing and amyloid readouts\",\n      \"pmids\": [\"24405708\", \"25319692\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional role of soluble contactin-2 not established\", \"RTN3-BACE1 inhibitory mechanism not structurally defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"BACE1-APP interaction was mapped to recycling microdomains and synaptic compartments, the protective Icelandic APP mutation was shown to weaken this interaction, BACE1 was found enriched in synaptic vesicles, and Schwann-cell BACE1 was shown necessary for peripheral remyelination.\",\n      \"evidence\": \"Fluorescence complementation interaction assay with Icelandic mutant; synaptic vesicle isolation and proximity ligation; sciatic nerve transplantation between BACE1-null and WT\",\n      \"pmids\": [\"26642089\", \"26296617\", \"25740511\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of synaptic vs endosomal cleavage to total Aβ unclear\", \"Schwann vs axonal NRG1 source contributions not fully apportioned\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"sAPPα was identified as an endogenous allosteric BACE1 inhibitor whose activity depends on a conformation lost in sAPPβ, revealing a product-level negative feedback on the protease.\",\n      \"evidence\": \"In vitro BACE1 inhibition with recombinant sAPPα and small-angle X-ray scattering comparison\",\n      \"pmids\": [\"26401691\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Allosteric site not confirmed by mutagenesis\", \"In vivo relevance of inhibition not tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"USP8-mediated deubiquitination at Lys501 and autophagy-lysosomal turnover were defined as opposing arms controlling endosomal BACE1 retention versus degradation.\",\n      \"evidence\": \"USP8 RNAi with ubiquitination and substrate-processing assays; axonal autophagic vacuole imaging with Snapin overexpression in mutant APP neurons\",\n      \"pmids\": [\"27302062\", \"28028177\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase acting at Lys501 not identified\", \"Each mechanism from single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Par3/aPKC phosphorylation of BACE1-Ser498 and p75-mediated co-localization defined phosphorylation-controlled retrograde and amyloidogenic trafficking of BACE1, with reduced Ser498 phosphorylation in AD brain.\",\n      \"evidence\": \"Par3/aPKC perturbation with phospho-Ser498 analysis and BACE1-PACS1 Co-IP; p75-BACE1 Co-IP with JNK inhibition in cortical neurons\",\n      \"pmids\": [\"28946017\", \"28869759\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"p75 finding rests on Co-IP and co-localization without reciprocal validation\", \"Kinase specificity for Ser498 across pathways not reconciled\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"MMP13 was shown to control BACE1 translationally via PI3K/eIF4B and the BACE1 5'UTR, adding a translational regulatory node with in vivo amyloid impact.\",\n      \"evidence\": \"Promoter/5'UTR luciferase screen, eIF4B S422R mutagenesis, 5'UTR deletion, and Mmp13 knockdown in APP/PS1 mice\",\n      \"pmids\": [\"30596903\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How MMP13 signals to PI3K not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"AP-2 was established as the adaptor routing internalized BACE1 to lysosomes, with genetic rescue confirming BACE1 as the causal amyloidogenic node downstream of AP-2 loss.\",\n      \"evidence\": \"Conditional AP-2 KO mice and iPSC AD neurons with BACE1-deletion genetic rescue\",\n      \"pmids\": [\"32323475\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct AP-2 recognition motif on BACE1 not defined\", \"Relationship to the di-leucine lysosomal motif not reconciled\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"BACE1 was shown to be required for synaptic vesicle docking and LTP via mGluR1, and Rab35/OCRL was identified as sorting BACE1 out of the amyloidogenic endosomal route.\",\n      \"evidence\": \"BACE1 KO and inhibitors with EM vesicle docking, LTP, behavior, and mGluR1 PAM rescue; Rab35 overexpression/knockdown with OCRL/ACAP2 effector studies\",\n      \"pmids\": [\"34158621\", \"34876559\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrate cleavage event linking BACE1 to vesicle docking not identified\", \"How mGluR1 levels depend on BACE1 unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Cell-type-specific deletion revealed microglial BACE1 restrains protective phagocytic and disease-associated microglial programs by cleaving IL-1R2 and Toll-like receptors, repositioning BACE1 as an immune regulator in amyloid clearance.\",\n      \"evidence\": \"Microglial Bace1 deletion in 5xFAD mice with scRNA-seq, phagocytosis and signaling assays, plaque and LTP readouts\",\n      \"pmids\": [\"35857844\", \"35714196\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct cleavage of IL-1R2/TLRs not mapped at residue level\", \"Translation to non-5xFAD contexts untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Astrocytic BACE1 was shown to cleave insulin receptors, and its deletion enhances Clusterin-dependent Aβ clearance, defining a glial substrate-to-clearance axis.\",\n      \"evidence\": \"Astrocyte-specific Bace1 KO in 5xFAD with scRNA-seq, siRNA, Aβ uptake/degradation, and plaque quantification\",\n      \"pmids\": [\"37143090\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Insulin receptor cleavage site not mapped\", \"Direct Clusterin regulation mechanism downstream of IR signaling not fully defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"BACE1 dimerization was proposed as a determinant of catalytic activity, raising the question of how oligomeric state shapes function.\",\n      \"evidence\": \"Biochemical dimerization and active-site mutagenesis analysis of human brain BACE1\",\n      \"pmids\": [\"17047367\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Limited mechanistic detail and single study\", \"Functional consequence of dimerization not independently confirmed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the many trafficking, transcriptional, translational, and post-translational regulators integrate to set BACE1 activity at specific membranes, and which substrate cleavages mediate its non-amyloid synaptic and glial functions, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Substrates linking BACE1 to vesicle docking and LTP unidentified\", \"Cleavage sites for several glial/immune substrates unmapped\", \"Integration of competing trafficking regulators not reconciled into a unified model\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2, 8, 11, 19, 30]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [8, 19, 31]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [12, 13, 14, 23, 34, 35]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [4, 16, 26]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 19, 30]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [17, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [12, 13, 26, 32]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [8, 19, 4, 5]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 10, 6, 30]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [28, 29]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 11, 25]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"APP\", \"NRG1\", \"GGA3\", \"USP8\", \"RTN3\", \"SNX12\", \"PACS1\", \"SUMO1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}